DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 153 filers reported holding DIPLOMAT PHARMACY INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,162,000 | +69.4% | 1,540,966 | +107.6% | 0.00% | 0.0% |
| Q3 2019 | $3,637,000 | -14.9% | 742,278 | +5.7% | 0.00% | 0.0% |
| Q2 2019 | $4,275,000 | +12.6% | 702,114 | +7.4% | 0.00% | 0.0% |
| Q1 2019 | $3,797,000 | -76.4% | 653,680 | -45.4% | 0.00% | -50.0% |
| Q4 2018 | $16,118,000 | +57.2% | 1,197,506 | +126.7% | 0.00% | -33.3% |
| Q3 2018 | $10,252,000 | -13.6% | 528,225 | +13.8% | 0.00% | -25.0% |
| Q2 2018 | $11,859,000 | +46.8% | 464,012 | +15.7% | 0.00% | +33.3% |
| Q1 2018 | $8,078,000 | -9.7% | 400,929 | -10.1% | 0.00% | 0.0% |
| Q4 2017 | $8,949,000 | +17.5% | 445,904 | +21.2% | 0.00% | 0.0% |
| Q3 2017 | $7,619,000 | +35.2% | 367,921 | -3.4% | 0.00% | +50.0% |
| Q2 2017 | $5,636,000 | +9.0% | 380,873 | +17.5% | 0.00% | 0.0% |
| Q1 2017 | $5,170,000 | -8.9% | 324,194 | -28.1% | 0.00% | -33.3% |
| Q4 2016 | $5,678,000 | -26.9% | 450,707 | +62.6% | 0.00% | -25.0% |
| Q3 2016 | $7,765,000 | -12.6% | 277,247 | +9.2% | 0.00% | -20.0% |
| Q2 2016 | $8,883,000 | +45.4% | 253,828 | +13.8% | 0.01% | +66.7% |
| Q1 2016 | $6,110,000 | -18.6% | 223,011 | +1.7% | 0.00% | -25.0% |
| Q4 2015 | $7,504,000 | +26.7% | 219,308 | +6.4% | 0.00% | 0.0% |
| Q3 2015 | $5,921,000 | -35.1% | 206,125 | +1.2% | 0.00% | -20.0% |
| Q2 2015 | $9,117,000 | +218.4% | 203,749 | +146.0% | 0.01% | +150.0% |
| Q1 2015 | $2,863,000 | +33.5% | 82,817 | +5.7% | 0.00% | +100.0% |
| Q4 2014 | $2,144,000 | – | 78,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|